◆ 会议时间：2025年9月10-12日
◆ 会议地点：荷兰 乌得勒支

◆ 会议简介：

2025年第9届CRI-ENCI国际癌症免疫治疗大会将于2025年9月10-12日在荷兰乌得勒支举行，会议议题涵盖癌症免疫学和免疫治疗的所有研究领域。该会议于2015年启动，本次会议由癌症研究所（CRI）、欧洲癌症免疫治疗网络(ENCI)联合主办。会议每年举行一次，在美国和欧洲之间轮流举行。通过这种合作，这些组织旨在更有效地传播癌症免疫学和免疫治疗方面最前沿的信息和研究，并为该领域宣所有利益相关者提供交流、学习和沟通的机会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

CICON 2025
CRI-ENCI Ninth International Cancer Immunotherapy Conference: Translating Science into Survival

Dates:
September 10-12, 2025

Venue:
Beatrix Theater | Jaarbeurs
Utrecht, The Netherlands

Organized by:
Cancer Research Institute (CRI)
European Network for Cancer Immunotherapy (ENCI)

The Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI) are proud to present the Ninth International Cancer lmmunotherapy Conference CICON25, taking place September 10-12, 2025, in Utrecht, The Netherlands.

The CICON meeting series was launched in 2015 as a transnational forum for basic and translational research in cancer immunology and immunotherapy.

Presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), and alternating between the United States and Europe, CICON is organized by the leaders of this fast-moving field, gathering more than 1,000 cancer immunology and immunotherapy specialists from all over the world.

摘要征文投稿：

Abstract submission for CICON is now open through June 1, 2025.

点此提交摘要>>>Submit Abstract>>>

• Abstract Submission Guidelines

To submit an abstract, presenters must first register for CICON25. Once registered, you will receive a unique conference registration number. This number is required for the online abstract submission. Abstract submissions cannot be completed without prior conference registration and the associated registration number.

ABSTRACT SUBMISSION CATEGORIES

New Targets and Lead Structures
Submit your abstract in this session if you report on an exciting new target structure, or if you work on the development of innovative lead structures or therapeutic platforms.

Tumor Microenvironment and Immunosuppression
This session is dedicated to the complexity of cancer-immune interactions in the tumor microenvironment and to understanding the suppressive mechanisms that constrain anti-tumor immune responses.

Computational Immunology
Computational immunology is all about developing and utilizing computational tools that help us to analyze large amounts of data and harnessing AI models to improve cancer immunotherapy.

Cellular Therapies
From T-cell receptor treatments to chimeric antigen receptor innovations and beyond: This category covers all approaches in cellular therapy, encompassing diverse cell types and therapeutic strategies.

Biomarker Strategies
Accurate biomarkers are essential for the successful translation of cancer immunotherapies. If you have novel insights into predicting treatment-related effects such as response and toxicity, we encourage you to submit your abstract under this category.

注册费：

◆ 参会对象：
科学家，临床医生，监管机构，药物开发人员和患者权益倡导者，以及其他相关卫生保健专业人士。